EVOTEC SE (EVT.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:EVT - DE0005664809 - Common Stock
5.388 EUR
+0.16 (+3.1%)
EVT gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 19 industry peers in the Life Sciences Tools & Services industry. While EVT seems to be doing ok healthwise, there are quite some concerns on its profitability. EVT does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
In the past year EVT has reported negative net income.
In the past year EVT had a positive cash flow from operations.
In multiple years EVT reported negative net income over the last 5 years.
In the past 5 years EVT always reported a positive cash flow from operatings.
1.2 Ratios
Looking at the Return On Assets, with a value of -8.97%, EVT is doing worse than 94.74% of the companies in the same industry.
Looking at the Return On Equity, with a value of -19.87%, EVT is doing worse than 89.47% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -8.97% | ||
| ROE | -19.87% | ||
| ROIC | N/A |
ROA(3y)-7.25%
ROA(5y)-2.34%
ROE(3y)-14.29%
ROE(5y)-5.27%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
EVT has a worse Gross Margin (10.82%) than 94.74% of its industry peers.
EVT's Gross Margin has declined in the last couple of years.
EVT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 10.82% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-16.23%
GM growth 5Y-13.5%
2. Health
2.1 Basic Checks
EVT does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, EVT has more shares outstanding
The number of shares outstanding for EVT has been increased compared to 5 years ago.
EVT has a better debt/assets ratio than last year.
2.2 Solvency
EVT has an Altman-Z score of 1.08. This is a bad value and indicates that EVT is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 1.08, EVT is not doing good in the industry: 78.95% of the companies in the same industry are doing better.
EVT has a Debt/Equity ratio of 0.48. This is a healthy value indicating a solid balance between debt and equity.
EVT's Debt to Equity ratio of 0.48 is fine compared to the rest of the industry. EVT outperforms 63.16% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.48 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.08 |
ROIC/WACCN/A
WACC7.73%
2.3 Liquidity
A Current Ratio of 2.12 indicates that EVT has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 2.12, EVT belongs to the top of the industry, outperforming 94.74% of the companies in the same industry.
A Quick Ratio of 2.03 indicates that EVT has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 2.03, EVT belongs to the top of the industry, outperforming 94.74% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.12 | ||
| Quick Ratio | 2.03 |
3. Growth
3.1 Past
The earnings per share for EVT have decreased strongly by -136.17% in the last year.
The Revenue has decreased by -2.67% in the past year.
EVT shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 12.29% yearly.
EPS 1Y (TTM)-136.17%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-9.09%
Revenue 1Y (TTM)-2.67%
Revenue growth 3Y8.85%
Revenue growth 5Y12.29%
Sales Q2Q%-11.36%
3.2 Future
The Earnings Per Share is expected to grow by 18.47% on average over the next years. This is quite good.
The Revenue is expected to grow by 5.09% on average over the next years.
EPS Next Y62.04%
EPS Next 2Y36.34%
EPS Next 3Y28%
EPS Next 5Y18.47%
Revenue Next Year-2.93%
Revenue Next 2Y2.64%
Revenue Next 3Y5.43%
Revenue Next 5Y5.09%
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
EVT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year EVT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
94.74% of the companies in the same industry are cheaper than EVT, based on the Enterprise Value to EBITDA ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 1128.99 |
4.3 Compensation for Growth
EVT's earnings are expected to grow with 28.00% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y36.34%
EPS Next 3Y28%
5. Dividend
5.1 Amount
EVT does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
FRA:EVT (12/23/2025, 7:00:00 PM)
5.388
+0.16 (+3.1%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners54.68%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.91B
Revenue(TTM)756.33M
Net Income(TTM)-158.98M
Analysts78.46
Price Target9.07 (68.34%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-64.24%
Min EPS beat(2)-106.63%
Max EPS beat(2)-21.86%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-6.97%
Min Revenue beat(2)-9.17%
Max Revenue beat(2)-4.77%
Revenue beat(4)0
Avg Revenue beat(4)-4.99%
Min Revenue beat(4)-9.17%
Max Revenue beat(4)-0.93%
Revenue beat(8)1
Avg Revenue beat(8)-3.74%
Revenue beat(12)4
Avg Revenue beat(12)1.12%
Revenue beat(16)7
Avg Revenue beat(16)2.95%
PT rev (1m)-1.76%
PT rev (3m)-4.01%
EPS NQ rev (1m)0%
EPS NQ rev (3m)733.33%
EPS NY rev (1m)5.75%
EPS NY rev (3m)10.92%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)6.28%
Revenue NY rev (1m)-0.68%
Revenue NY rev (3m)-1.74%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 2.53 | ||
| P/FCF | N/A | ||
| P/OCF | 1356.96 | ||
| P/B | 2.39 | ||
| P/tB | 3.83 | ||
| EV/EBITDA | 1128.99 |
EPS(TTM)-1.11
EYN/A
EPS(NY)-0.16
Fwd EYN/A
FCF(TTM)-0.26
FCFYN/A
OCF(TTM)0
OCFY0.07%
SpS2.13
BVpS2.25
TBVpS1.41
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -8.97% | ||
| ROE | -19.87% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 10.82% | ||
| FCFM | N/A |
ROA(3y)-7.25%
ROA(5y)-2.34%
ROE(3y)-14.29%
ROE(5y)-5.27%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-16.23%
GM growth 5Y-13.5%
F-Score4
Asset Turnover0.43
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.48 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 209.82 | ||
| Cap/Depr | 90.72% | ||
| Cap/Sales | 12.19% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 76.3% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.12 | ||
| Quick Ratio | 2.03 | ||
| Altman-Z | 1.08 |
F-Score4
WACC7.73%
ROIC/WACCN/A
Cap/Depr(3y)186.39%
Cap/Depr(5y)182.37%
Cap/Sales(3y)22.79%
Cap/Sales(5y)21.48%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-136.17%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-9.09%
EPS Next Y62.04%
EPS Next 2Y36.34%
EPS Next 3Y28%
EPS Next 5Y18.47%
Revenue 1Y (TTM)-2.67%
Revenue growth 3Y8.85%
Revenue growth 5Y12.29%
Sales Q2Q%-11.36%
Revenue Next Year-2.93%
Revenue Next 2Y2.64%
Revenue Next 3Y5.43%
Revenue Next 5Y5.09%
EBIT growth 1Y-6.57%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year131.73%
EBIT Next 3Y48.36%
EBIT Next 5Y33.1%
FCF growth 1Y52.83%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y107.69%
OCF growth 3Y-46.98%
OCF growth 5Y-15.47%
EVOTEC SE / EVT.DE FAQ
Can you provide the ChartMill fundamental rating for EVOTEC SE?
ChartMill assigns a fundamental rating of 3 / 10 to EVT.DE.
Can you provide the valuation status for EVOTEC SE?
ChartMill assigns a valuation rating of 1 / 10 to EVOTEC SE (EVT.DE). This can be considered as Overvalued.
How profitable is EVOTEC SE (EVT.DE) stock?
EVOTEC SE (EVT.DE) has a profitability rating of 1 / 10.
How financially healthy is EVOTEC SE?
The financial health rating of EVOTEC SE (EVT.DE) is 5 / 10.